
D-ERYTHRO-SPHINGOSINE
CAS No. 123-78-4
D-ERYTHRO-SPHINGOSINE( Erythrosphingosine | erythro-C18-Sphingosine | trans-4-Sphingenine )
Catalog No. M20525 CAS No. 123-78-4
D-erythro-Sphingosine is a protein kinase C (PKC) inhibitor. D-erythro-Sphingosine (Erythrosphingosine) is also a PP2A activator.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
10MG | 35 | In Stock |
![]() ![]() |
25MG | 58 | In Stock |
![]() ![]() |
50MG | 102 | In Stock |
![]() ![]() |
100MG | 155 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameD-ERYTHRO-SPHINGOSINE
-
NoteResearch use only, not for human use.
-
Brief DescriptionD-erythro-Sphingosine is a protein kinase C (PKC) inhibitor. D-erythro-Sphingosine (Erythrosphingosine) is also a PP2A activator.
-
DescriptionD-erythro-Sphingosine is a protein kinase C (PKC) inhibitor. D-erythro-Sphingosine (Erythrosphingosine) is also a PP2A activator
-
In Vitro——
-
In Vivo——
-
SynonymsErythrosphingosine | erythro-C18-Sphingosine | trans-4-Sphingenine
-
PathwayAngiogenesis
-
TargetPKC
-
RecptorPKC|PP2A|Human Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number123-78-4
-
Formula Weight299.49
-
Molecular FormulaC18H37NO2
-
Purity>98% (HPLC)
-
SolubilityDMSO:250 mg/mL (834.75 mM)
-
SMILESCCCCCCCCCCCCC\C=C\C(O)C(N)CO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Khan W A Dobrowsky R El T S et al. Protein kinase C and platelet inhibition by D-erythro-sphingosine: comparison with NN-dimethylsphingosine and commercial preparation.[J]. Biochemical & Biophysical Research Communications 1990 172(2):683-691.
molnova catalog



related products
-
PKC-IN-7
PKC-IN-7 is a potent, selective, reversible, ATP-competitive PKCα/β inhibitor with IC50 of 4.7/3.3 nM.
-
DCPLA-ME
DCPLA-ME is the methyl ester form of DCPLA and can be used to treat neurodegenerative diseases. It is an effective PKCε activator.
-
Roy-Bz
Roy-Bz is the?first?small-molecule?PKCδ-selective activator with EC50 of 58.5 nM, binds to the PKCδ-C1-domain.